---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-26-000056"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:15:01.408267+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# West Pharmaceutical holds 2026 annual meeting; all proposals pass except shareholder chair proposal

## Summary
- Eleven directors elected to one-year terms; all received majority support with >57M votes each.
- Non-binding say-on-pay approved with 60.1M for, 3.8M against, 80K abstain.
- Ratification of PwC as auditor for FY2026 passed with 58.5M for, 7.6M against.
- Shareholder proposal for independent board chair policy not approved: 29.6M for, 34.2M against.
- Total shares represented: 66.2M (91.83% of outstanding).

## SEC filing metadata
- accession: 0000105770-26-000056
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/wst-20260504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-26-000056
- JSON: https://secwatch.observer/filing/0000105770-26-000056.json
- Plain text: https://secwatch.observer/filing/0000105770-26-000056.txt

## Key facts
- Shareholder Votes
  WEST PHARMACEUTICAL SERVICES INC shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal 2026 at the 2026-05-04 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-05-04
  source text: Proposal 3: The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was ratified as set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm
- Shareholder Votes
  WEST PHARMACEUTICAL SERVICES INC shareholders rejected Shareholder proposal regarding an Independent Board Chair Policy at the 2026-05-04 meeting.
  - Outcome: failed
  - Meeting: 2026-05-04
  source text: Proposal 4: The shareholder proposal regarding an Independent Board Chair Policy was not approved as set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm
- Shareholder Votes
  WEST PHARMACEUTICAL SERVICES INC shareholders approved Non-binding advisory vote to approve the compensation of the Company's named executive officers at the 2026-05-04 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-05-04
  source text: Proposal 2: The non-binding advisory vote to approve the compensation of the Company's named executive officers was approved as set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm
- Shareholder Votes
  WEST PHARMACEUTICAL SERVICES INC shareholders approved Election of eleven nominees as directors to serve until the 2027 Annual Meeting of Shareholders at the 2026-05-04 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-05-04
  source text: Proposal 1: The eleven nominees, as set forth below and in the Company's 2026 Proxy Statement, were elected as directors, each to serve until the 2027 Annual Meeting of Shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/105770/000010577026000056/0000105770-26-000056-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.